Doxorubicin Terminated Phase 2 Trials for Fallopian Tube Cancer / Peritoneal Cavity Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00653328Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma